IL17A and asthma: A recent study found ILC3 (IL-17+RORγt+) cells were responsible for the development of airway hyperreactivity (AHR) induced by IL-1β in obese mice asthma model, and blockade of IL-1β abolished the AHR and reduced the number of ILC3 cells [6].